United States · FDA National Drug Code directory
EPYSQLI
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 51759-208_4898d7e0-c6d4-4fd7-8da2-b122296521ea
- Product NDC
- 51759-208
- Form
- INJECTION, SOLUTION
- Composition / generic term
- Eculizumab-aagh
- Labeler
- Teva Pharmaceuticals USA, Inc.
- Marketing category
- BLA
- Marketing start / end (source format)
- 20250407
- Source listing expiry
- 20271231
Source-listed ingredients
- ECULIZUMAB — 300 mg/30mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL, SINGLE-DOSE in 1 CARTON (51759-208-13) / 30 mL in 1 VIAL, SINGLE-DOSE · 51759-208-13
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →